Bacopa Monnieri As Augmentation Therapy In The Treatment Of Anhedonia, Preclinical And Clinical Evaluation
Notes for this study:
|Number of Subjects
In a 4-week randomized trial, 42 participants took either 600 mg of Bacopa titrated at 20% bacosides along with conventional treatment with citalopram, while the other group only received conventional treatment.
Anhedonia and depression were lower at the end of the study for those taking bacopa. There wasn't a statistically significant difference on the Temporal Experience of Pleasure Scales.